<DOC>
	<DOCNO>NCT02366013</DOCNO>
	<brief_summary>This dose escalation study test safety immunogenicity oral HIV-1 vaccine .</brief_summary>
	<brief_title>Trial Safety Immunogenicity Oral , Replicating Ad26 Vectored HIV-1 Vaccine</brief_title>
	<detailed_description>This study phase I dose-escalation randomized , double blind , placebo-controlled study design evaluate safety immunogenicity rcAd26.MOS1.HIV-Env , oral replicate adenovirus 26 vector vaccine healthy HIV-1 uninfected adult . The vaccine administer orally single time point ( Day 0 ) one four dose level depend study group : 1 x 10^8 virus particle ( vp ) , 1 x 10^9 vp , 1 x 10^10 vp 1 x 10^11 vp . Volunteers randomize vaccine : placebo 5:1 ratio group . Volunteers screen 56 day vaccination follow 12 month vaccination . Because vaccine replication competent , volunteer house isolation unit day -2 day 9 . Household contact also enrol test possible transmission .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 1840 year old . Ability willingness provide inform consent . Complete assessment understand Available duration trial , include willingness keep isolation facility From Day 10 4 month follow vaccination must reside alone 2 adult ( age 1860 ) minor age 18 Good general health show medical history , physical exam , screen Willing undergo HIV test willing receive risk reduction counsel All female volunteer must willing undergo urine pregnancy test Sexually active male must willing use effective method contraception least 4 month vaccination Women child bear potential commit use effective method contraception sexually active male 4 month vaccination Willing forgo donation blood tissue study , test HIV positive due trial vaccination ( vaccineinduced HIV seroreactivity ) , antiHIV antibody titer become undetectable Low risk HIV infection willing maintain lowrisk behavior trial duration Confirmed HIV1 HIV2 infection ; confirm HCV , HBV , syphilis infection Current plan participation another clinical trial experimental agent study period Pregnant lactating Significant acute chronic disease , include inflammatory bowel disease chronic gastrointestinal disease , immunodeficiency syndrome , condition require immunosuppressant medication Use anticancer , antituberculosis medication consider significant investigator within previous 6 month Receipt liveattenuated vaccine within previous 60 day plan receipt within 60 day vaccination Investigational Product ( within 14 day live attenuated influenza vaccine [ LAIV ] ) ; receipt vaccine ( e.g. , influenza , pneumococcal ) , allergy treatment antigen injection tuberculin skin test within previous 14 day plan receipt within 14 day vaccination Investigational Product Receipt blood transfusion bloodderived product within previous 3 month Receipt HIV vaccine ( ) prior HIV vaccine trial . Previous severe local systemic reaction vaccination History splenectomy History seizure last 3 year Known autoimmune disease Asthma mild , wellcontrolled asthma . Diabetes mellitus type 1 type 2 Thyroidectomy , thyroid disease require medication last 12 month Angioedema within last 3 year episodes consider serious require medication within last 2 year Hypertension Body mass index ( BMI ) â‰¥ 40 Bleeding disorder diagnose doctor Malignancy ( Not exclude : volunteer surgical excision subsequent observation period investigator 's estimation reasonable assurance sustain cure unlikely recur study period ) Psychiatric condition compromise safety volunteer precludes compliance protocol All healthcare worker direct patient contact Childcare worker direct contact child Individuals employ food handler otherwise engage preparation delivery food outside place residence Positive urine toxicology test Household contact 1860 year age also evaluate eligibility abbreviate list inclusion/exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>HIV Prevention</keyword>
	<keyword>HIV Vaccine</keyword>
	<keyword>Healthy</keyword>
</DOC>